<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-jpm-11-00158">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Konopleva</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Martinelli</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Daver</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Papayannidis</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Higgins</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ott</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mascarenhas</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Andreeff</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>MDM2 inhibition: An important step forward in cancer therapy</article-title>
  <source>Leukemia</source>
  <year>2020</year>
  <volume>34</volume>
  <fpage>2858</fpage>
  <lpage>2874</lpage>
  <pub-id pub-id-type="doi">10.1038/s41375-020-0949-z</pub-id>
  <pub-id pub-id-type="pmid">32651541</pub-id>
 </element-citation>
</ref>
